School of Medicine
Showing 1-10 of 20 Results
-
Nicholas Antonios Kalogriopoulos
Postdoctoral Research Fellow, Genetics
BioNick's broad research interests are in developing tools and technologies for research and therapeutic applications. Nick obtained a B.S. in Genetics and Molecular Biology from the University of Wisconsin-Madison. During his undergraduate career, he trained with Dr. Paul Sondel, where he worked on preclinical testing of novel immunotherapeutic agents for the treatment of neuroblastoma. He obtained a Ph.D. in Biomedical Science with Dr. Pradipta Ghosh, elucidating the structural basis of non-canonical G protein activation by a novel protein family of Guanine Nucleotide Exchange Modulators (GEMs). As a Postdoctoral Researcher with Professor Alice Ting at Stanford University, his current research focuses on developing a new system for programmable and user-controlled cellular behaviors for immuno-oncology applications.
-
Saswati Karmakar
Postdoctoral Research Fellow, Genetics
BioSaswati Karmakar obtained her undergraduate degree in Biotechnology at Guru Gobind Singh Indraprastha University, New Delhi. She pursued her Ph.D. in Biochemistry and Molecular Biology at the University of Nebraska Medical Center, Omaha, working on the molecular characterization of pancreatic cancer stem cells and their contribution to cancer initiation and progression. Then, she moved to Stanford University with the National Cancer Institute's F99/K00 award for a postdoctoral position in Monte Winslow's lab. Saswati's current research explores the role of tumor suppressor genes in pancreatic cancer pathogenesis.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor in Pediatrics, and Professor of Genetics
On Partial Leave from 01/15/2021 To 04/15/2021Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
